Home Other Building Blocks Piperidine,1-[(2,3-dihydro-1,4-benzodioxin-2-yl)methyl]-

Piperidine,1-[(2,3-dihydro-1,4-benzodioxin-2-yl)methyl]-

CAS No.:
59-39-2
Catalog Number:
AG0039FR
Molecular Formula:
C14H19NO2
Molecular Weight:
233.3062
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
Product Description
Catalog Number:
AG0039FR
Chemical Name:
Piperidine,1-[(2,3-dihydro-1,4-benzodioxin-2-yl)methyl]-
CAS Number:
59-39-2
Molecular Formula:
C14H19NO2
Molecular Weight:
233.3062
MDL Number:
MFCD00242712
IUPAC Name:
1-(2,3-dihydro-1,4-benzodioxin-3-ylmethyl)piperidine
InChI:
InChI=1S/C14H19NO2/c1-4-8-15(9-5-1)10-12-11-16-13-6-2-3-7-14(13)17-12/h2-3,6-7,12H,1,4-5,8-11H2
InChI Key:
LYKMMUBOEFYJQG-UHFFFAOYSA-N
SMILES:
C1CCN(CC1)CC1COc2c(O1)cccc2
Properties
Complexity:
240  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
233.142g/mol
Formal Charge:
0
Heavy Atom Count:
17  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
0
Isotope Atom Count:
0
Molecular Weight:
233.311g/mol
Monoisotopic Mass:
233.142g/mol
Rotatable Bond Count:
2  
Topological Polar Surface Area:
21.7A^2
Undefined Atom Stereocenter Count:
1  
Undefined Bond Stereocenter Count:
0
XLogP3:
2.6  
Literature
Title Journal
Chronic treatment with the α2-adrenoceptor antagonist fluparoxan prevents age-related deficits in spatial working memory in APP×PS1 transgenic mice without altering β-amyloid plaque load or astrocytosis. Neuropharmacology 20110101
Role of alpha-2 adrenergic receptors in anti-ulcer effect mechanism of estrogen and luteinising hormone on rats. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20090401
Nasal trigeminal inputs release the A5 inhibition received by the respiratory rhythm generator of the mouse neonate. Journal of neurophysiology 20040201
Development of a segmented model for a continuous electrophoretic moving bed enantiomer separation. Biotechnology progress 20030101
Continuous fractionation of enantiomer pairs in free solution using an electrophoretic analog of simulated moving bed chromatography. Journal of chromatography. A 20020412
Use of dyes to investigate migration of the chiral selector in CFFE and the impact on the chiral separations. Analytical chemistry 20010815
Agonist and antagonist actions of yohimbine as compared to fluparoxan at alpha(2)-adrenergic receptors (AR)s, serotonin (5-HT)(1A), 5-HT(1B), 5-HT(1D) and dopamine D(2) and D(3) receptors. Significance for the modulation of frontocortical monoaminergic transmission and depressive states. Synapse (New York, N.Y.) 20000201
Inhibitory effects of clonidine and tizanidine on release of substance P from slices of rat spinal cord and antagonism by alpha-adrenergic receptor antagonists. Neuropharmacology 19910601
Antagonists of adenosine and alpha-2-adrenoceptors reverse the anticonvulsant effects of tizanidine in DBA/2 mice. Neuropharmacology 19890301
Norepinephrine inhibition of pulsatile LH release: receptor specificity. The American journal of physiology 19860201
Pharmacological properties of (N-dicyclopropylmethyl) amino-2-oxazoline (S 3341), an alpha-2 adrenoceptor agonist. Journal de pharmacologie 19850101
[Comparative study of piperoxan and 2-(2-imidazolinyl)-1, 4-benzodioxane (170 150) on pre- and postsynaptic receptors in the rat]. Journal de pharmacologie 19820101
Pharmacological characteristics of spinal alpha-adrenoreceptors in rats. Journal of autonomic pharmacology 19810301
Noradrenergic influences on sound-induced seizures. The Journal of pharmacology and experimental therapeutics 19800801
The role of alpha receptors in the facilitation of the chemoreflex and inhibition of the carotid occlusion reflex by clonidine. Clinical and experimental hypertension 19800101
A comparison of the cardiovascular effects of centrally administered clonidine and adrenaline in the anaesthetized rat. The Journal of pharmacy and pharmacology 19790101
Differentiation of drugs acting centrally upon the cardiovascular system by means of sympathetic and vagal responses. Clinical and experimental hypertension 19780101
Cardiovascular changes in anaesthetised rats after the intra-hypothalamic administration of adrenaline. Clinical and experimental hypertension 19780101
Properties